{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:04:58Z","timestamp":1789974298654,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.vhri.2026.101645","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:56:20Z","timestamp":1782939380000},"page":"101645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-World Evidence in Asian Health Technology Assessment: Evolving Roles, Practices, and Future Directions (2015-2024)"],"prefix":"10.1016","volume":"57","author":[{"given":"Daisuke","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Sun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2026.101645_bib1","doi-asserted-by":"crossref","unstructured":"Kumar R, Suharlim C, Caruso AA, Gilmartin C, Mehra M, Castro HE. Assessing progression of health technology assessment implementation in Asia: a balanced scorecard for cross comparison of selected countries in Asia. Int J Technol Assess Health Care;38(1):e60.","DOI":"10.1017\/S0266462322000423"},{"key":"10.1016\/j.vhri.2026.101645_bib2","doi-asserted-by":"crossref","unstructured":"Roberts MH, Ferguson GT. Real-world evidence: bridging gaps in evidence to guide payer decisions. Pharmacoecon Open;5(1):3-11.","DOI":"10.1007\/s41669-020-00221-y"},{"key":"10.1016\/j.vhri.2026.101645_bib3","author":"Petcharapiruch"},{"key":"10.1016\/j.vhri.2026.101645_bib4","article-title":"Using real-world evidence for health technology assessment in Asia: suggested typology and scoping review","volume":"46","author":"Nugraha RR, Rahadi A, Suharlim C","year":"2025","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.vhri.2026.101645_bib5","author":"Sem"},{"key":"10.1016\/j.vhri.2026.101645_bib6","article-title":"Analysis of implementation and termination characteristics of managed entry agreements for new drugs under Taiwan's National Health Insurance system.","volume":"49(Suppl 1)","author":"Hsiao","year":"2025","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.vhri.2026.101645_bib10","author":"Lim"},{"key":"10.1016\/j.vhri.2026.101645_bib11","doi-asserted-by":"crossref","unstructured":"Babic T, Roberts M, Astill J, Smith S. HTA82 use of real-world evidence in HTA submissions and cost-effectiveness evaluations in Asia. Value Health;28(6):S261.","DOI":"10.1016\/j.jval.2025.04.1093"},{"key":"10.1016\/j.vhri.2026.101645_bib12","doi-asserted-by":"crossref","unstructured":"Wang W, Tan J, Qiu Y, et al. Use of real world data to improve drug coverage decisions in China. BMJ;381:e068911.","DOI":"10.1136\/bmj-2021-068911"},{"key":"10.1016\/j.vhri.2026.101645_bib13","doi-asserted-by":"crossref","unstructured":"Chen Q, Fan Y, Huang K. Cost-effectiveness of population-based screening for chronic obstructive pulmonary disease in China: a simulation modeling study. Lancet Reg Health West Pac;46:101065.","DOI":"10.1016\/j.lanwpc.2024.101065"},{"key":"10.1016\/j.vhri.2026.101645_bib15","author":"Wu"},{"key":"10.1016\/j.vhri.2026.101645_bib16","unstructured":"Wee HL, Zhao Z, Bucsics A. What, where, and how to collect real-world data and generate real-world evidence to support drug reimbursement decision-making in Asia: a reflection into the past and a way forward. Int J Health Policy Manag;12:6858."},{"key":"10.1016\/j.vhri.2026.101645_bib17","doi-asserted-by":"crossref","unstructured":"Zisis KZ, Pavi E, Geitona M, Athanasakis K. Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process. J Pharm Pharm Sci;27:12302.","DOI":"10.3389\/jpps.2024.12302"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:54:23Z","timestamp":1789973663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":13,"alternative-id":["S2212109926000609"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101645","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Evidence in Asian Health Technology Assessment: Evolving Roles, Practices, and Future Directions (2015-2024)","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101645"}}